Skip to article
Astra

Infectious Diseases

Meningitis Empiric Antibiotic Selection

Choose empiric therapy by acquisition setting, age, immune status, and neurosurgical hardware exposure; obtain blood cultures and CSF promptly, but do not delay antibiotics for imaging or lumbar puncture when either will defer treatment.

Clinical question: Which empiric antibiotic regimen should be started for suspected bacterial meningitis before microbiologic confirmation?

Immediate action

Start antibiotics after blood cultures; do not wait for lumbar puncture

Acquisition setting determines the initial regimen.

In suspected bacterial meningitis, draw blood cultures immediately and perform lumbar puncture for CSF microscopy, Gram stain, culture, and pathogen testing when feasible; initiate empiric treatment before CSF results return. ScienceDirectBacterial Meningitis - an overviewCDCMeningococcal Disease | CDC Yellow Book™ If neuroimaging or another barrier delays lumbar puncture, obtain blood cultures and give broad, age- and risk-appropriate antimicrobials rather than defer treatment. ScienceDirectEpidemic Meningitis - an overview | ScienceDirect Topics

For suspected community-acquired disease in immunocompetent adults age 50 years or younger, start vancomycin plus either ceftriaxone 2 g IV every 12 hours or cefotaxime 2 g IV every 4 hours. This combination covers the predominant adult pathogens, Streptococcus pneumoniae and Neisseria meningitidis, while addressing concern for cephalosporin-nonsusceptible pneumococci. PubMedEpidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis - PMCccjm[PDF] Acute community-acquired bacterial meningitis in adults

Initial empiric antimicrobial selection by clinical setting. IDSAIDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitisccjm[PDF] Acute community-acquired bacterial meningitis in adults
Clinical settingInitial regimenSelection rationale
Community-acquired; immunocompetent adult age 50 years or youngerVancomycin plus ceftriaxone 2 g IV every 12 hours or cefotaxime 2 g IV every 4 hours ccjm[PDF] Acute community-acquired bacterial meningitis in adultsCovers common adult pneumococcal and meningococcal disease and resistant pneumococci. PubMedEpidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis - PMCccjm[PDF] Acute community-acquired bacterial meningitis in adults
Community-acquired; age over 50 years or cell-mediated immunodeficiencyVancomycin plus ceftriaxone or cefotaxime, plus ampicillin 2 g IV every 4 hours ccjm[PDF] Acute community-acquired bacterial meningitis in adultsAdd ampicillin for L. monocytogenes coverage. ccjm[PDF] Acute community-acquired bacterial meningitis in adults
Healthcare-associated ventriculitis or meningitisVancomycin plus cefepime, ceftazidime, or meropenem IDSAIDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and MeningitisSelect the antipseudomonal beta-lactam according to local in vitro susceptibility patterns. IDSAIDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis
Severe beta-lactam anaphylaxis with healthcare-associated disease and meropenem contraindicatedVancomycin plus aztreonam or ciprofloxacin for gram-negative coverage IDSAIDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and MeningitisIDSA alternative when beta-lactams cannot be used. IDSAIDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis

Community acquired

Add ampicillin when Listeria risk changes the regimen

Age and cellular immune status are the practical discriminators.

Add ampicillin 2 g IV every 4 hours to vancomycin plus ceftriaxone or cefotaxime for patients older than 50 years and for those with cell-mediated immunodeficiency. ccjm[PDF] Acute community-acquired bacterial meningitis in adults Do not rely on a third-generation cephalosporin alone when Listeria is a credible pathogen, because the treatment branch specifically requires ampicillin coverage. ScienceDirectBacterial Meningitis - an overviewccjm[PDF] Acute community-acquired bacterial meningitis in adults

Vancomycin is included empirically because pneumococcal resistance can compromise beta-lactam-only therapy. PubMedEpidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis - PMCccjm[PDF] Acute community-acquired bacterial meningitis in adults A cited adult regimen uses vancomycin 45-60 mg/kg/day IV divided every 6 or 8 hours to improve CSF concentrations. ccjm[PDF] Acute community-acquired bacterial meningitis in adults Once an organism and susceptibility profile are available, narrow the regimen rather than continuing broad combination therapy by default. ccjm[PDF] Acute community-acquired bacterial meningitis in adults

Microbiology results that alter empiric treatment. ScienceDirectBacterial Meningitis - an overviewCDCMeningococcal Disease | CDC Yellow Book™ccjm[PDF] Acute community-acquired bacterial meningitis in adults
Result or clinical determinationAction
N. meningitidis confirmed or suspectedContinue a third-generation cephalosporin initially; obtain isolate susceptibility before changing to penicillin or ampicillin. CDCMeningococcal Disease | CDC Yellow Book™
Pneumococcal cefotaxime or ceftriaxone MIC 0.5 micrograms/mL or lessCefotaxime or ceftriaxone is probably adequate. ScienceDirectBacterial Meningitis - an overview
Pneumococcal cefotaxime or ceftriaxone MIC 1 microgram/mL or moreUse vancomycin as the treatment of choice described in the cited review. ScienceDirectBacterial Meningitis - an overview
Culture and susceptibility availableTailor antimicrobial therapy to the identified pathogen and susceptibility profile. ccjm[PDF] Acute community-acquired bacterial meningitis in adults

Postprocedural disease

Use antipseudomonal gram-negative coverage after neurosurgical exposure

Do not apply the community-acquired regimen to hardware-associated infection.

For healthcare-associated ventriculitis or meningitis, initiate vancomycin plus cefepime, ceftazidime, or meropenem. IDSAIDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis This branch applies when the epidemiology is iatrogenic or postneurosurgical rather than community acquired, where gram-negative pathogens including Pseudomonas must be covered empirically. ScienceDirectBacterial Meningitis - an overviewIDSAIDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis

Choose cefepime, ceftazidime, or meropenem using local in vitro susceptibility data, and broaden or modify empiric coverage when the patient is colonized or infected elsewhere with a highly antimicrobial-resistant pathogen. IDSAIDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis In seriously ill adults receiving intermittent-bolus vancomycin, maintain a trough concentration of 15-20 micrograms/mL. IDSAIDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis

Healthcare-associated empiric regimen modifications. IDSAIDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis
ProblemEmpiric actionMonitoring or adjustment
Standard healthcare-associated ventriculitis or meningitisVancomycin plus cefepime, ceftazidime, or meropenem. IDSAIDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and MeningitisChoose the beta-lactam from local susceptibility patterns. IDSAIDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis
Known colonization or infection with a highly resistant organismAdjust the empiric regimen to cover that organism. IDSAIDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and MeningitisReassess after microbiologic results. IDSAIDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis
Seriously ill adult receiving intermittent vancomycinTarget vancomycin trough 15-20 micrograms/mL. IDSAIDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and MeningitisUse trough monitoring to maintain the recommended range. IDSAIDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis

Microbiologic direction

Use CSF Gram stain, culture, and PCR to narrow therapy

Negative culture after prior antibiotics does not exclude bacterial meningitis.

Send CSF for microscopic examination, Gram stain, and culture, with pathogen-specific PCR when meningococcal disease is suspected. N. meningitidis may be confirmed by culture or PCR from a normally sterile site such as blood or CSF; Gram stain provides rapid presumptive identification but is not confirmatory. CDCMeningococcal Disease | CDC Yellow Book™CDCMeningococcal Disease | Infection Control - CDC

Prior antibacterial therapy can reduce culture yield. In a 451-specimen study of pneumococcal, meningococcal, and H. influenzae meningitis, culture was positive in 17.7% and real-time PCR in 25.1%; latent-class sensitivity estimates were 81.3% for culture, 98.2% for Gram stain, and 95.7% for real-time PCR. CDC[PDF] Accuracy of real-time PCR, Gram stain and culture for ... - CDC Stacks Therefore, retain clinically appropriate empiric treatment while interpreting negative cultures in patients who received antibiotics before CSF collection. CDC[PDF] Accuracy of real-time PCR, Gram stain and culture for ... - CDC Stacks

Consider broad-range 16S rRNA PCR with sequencing for selected complex infections involving normally sterile fluids or tissues when conventional testing fails to identify a pathogen; it can detect fastidious bacteria and may support antimicrobial stewardship, although diagnostic yield varies by specimen and patient characteristics. CDC16S Ribosomal RNA Gene PCR and Sequencing for Pediatric Infection Diagnosis, United States, 2020–2023 - Volume 31, Supplement—May 2025 - Emerging Infectious Diseases journal - CDC

Interpretation of microbiologic tests in suspected bacterial meningitis. CDC[PDF] Accuracy of real-time PCR, Gram stain and culture for ... - CDC StacksCDCMeningococcal Disease | CDC Yellow Book™CDCMeningococcal Disease | Infection Control - CDCCDC16S Ribosomal RNA Gene PCR and Sequencing for Pediatric Infection Diagnosis, United States, 2020–2023 - Volume 31, Supplement—May 2025 - Emerging Infectious Diseases journal - CDC
TestInterpretationImmediate treatment implication
CSF Gram stainRapid presumptive organism identification; not confirmatory for N. meningitidis. CDCMeningococcal Disease | Infection Control - CDCUse the result to direct early narrowing only with the clinical context and confirmatory testing. CDCMeningococcal Disease | Infection Control - CDC
CSF or blood cultureDiagnostic reference method but sensitivity is limited after prior antibiotics. CDC[PDF] Accuracy of real-time PCR, Gram stain and culture for ... - CDC StacksUse isolate susceptibility to tailor therapy. ccjm[PDF] Acute community-acquired bacterial meningitis in adults
Pathogen-specific real-time PCRFor three common bacterial pathogens, sensitivity remained high in CSF with antibiotic activity in the cited study. CDC[PDF] Accuracy of real-time PCR, Gram stain and culture for ... - CDC StacksSupports microbiologic diagnosis when culture is negative after pretreatment. CDC[PDF] Accuracy of real-time PCR, Gram stain and culture for ... - CDC Stacks
16S rRNA PCR and sequencingMay identify bacteria in normally sterile specimens when conventional tests are unrevealing; yield is variable. CDC16S Ribosomal RNA Gene PCR and Sequencing for Pediatric Infection Diagnosis, United States, 2020–2023 - Volume 31, Supplement—May 2025 - Emerging Infectious Diseases journal - CDCConsider in complex culture-negative infection rather than as routine first-line testing. CDC16S Ribosomal RNA Gene PCR and Sequencing for Pediatric Infection Diagnosis, United States, 2020–2023 - Volume 31, Supplement—May 2025 - Emerging Infectious Diseases journal - CDC

Meningococcal disease

Separate index-patient treatment from contact prophylaxis

Organism confirmation triggers immediate public health action.

For the index patient with suspected meningococcal meningitis, a third-generation cephalosporin is recommended empirically. CDCMeningococcal Disease | CDC Yellow Book™ If dexamethasone was started for suspected bacterial meningitis, it can be discontinued when meningococcal meningitis is confirmed or suspected. CDCMeningococcal Disease | CDC Yellow Book™

For close contacts, rifampin, ciprofloxacin, and ceftriaxone are acceptable chemoprophylaxis agents and reduce nasopharyngeal meningococcal carriage by 90%-95%. CDCMeningococcal Disease | Infection Control - CDC Treat eligible contacts promptly; microbiologically unconfirmed cases require case-by-case prophylaxis decisions based on the source patient's epidemiologic and clinical likelihood of meningococcal disease. CDCMeningococcal Disease | Infection Control - CDC

Meningococcal management decisions. CDCMeningococcal Disease | CDC Yellow Book™CDCMeningococcal Disease | Infection Control - CDC
Decision pointAction
Suspected meningococcal meningitisUse a third-generation cephalosporin empirically. CDCMeningococcal Disease | CDC Yellow Book™
Considering penicillin or ampicillin de-escalationFirst determine meningococcal isolate susceptibility. CDCMeningococcal Disease | CDC Yellow Book™
Close contact identifiedProvide chemoprophylaxis ideally within 24 hours of index-patient identification. CDCMeningococcal Disease | Infection Control - CDC
More than 14 days after index illness onsetChemoprophylaxis is probably of limited or no value. CDCMeningococcal Disease | Infection Control - CDC

References

  1. [PDF] 209445Orig1s000 - accessdata.fda.govwww.accessdata.fda.gov · www.accessdata.fda.gov
  2. Empirical vancomycin therapy in childhood meningitis may not be necessary: Response to recent NICE guidelines | The BMJwww.bmj.com · www.bmj.com
  3. Management of bacterial meningitis and meningococcal septicaemia in children and young people: summary of NICE guidance | The BMJwww.bmj.com · www.bmj.com
  4. Opportunistic etiological agents causing lung infections - Cell Presswww.cell.com · www.cell.com
  5. Bacterial Meningitis - an overviewwww.sciencedirect.com · www.sciencedirect.com
  6. Epidemic Meningitis - an overview | ScienceDirect Topicswww.sciencedirect.com · www.sciencedirect.com
  7. Update on community-acquired bacterial meningitis: guidance and ...www.sciencedirect.com · www.sciencedirect.com
  8. Role of cephalosporins in the treatment of bacterial meningitis in adults: Overview with special emphasis on ceftazidime - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  9. Efficacy of Antibiotic Regimens for Meningitis in Young Infants Aged ...publications.aap.org · publications.aap.org
  10. Meningitis | Pediatric Care Online - AAP Publicationspublications.aap.org · publications.aap.org
  11. [PDF] Accuracy of real-time PCR, Gram stain and culture for ... - CDC Stacksstacks.cdc.gov · stacks.cdc.gov
  12. Meningococcal Disease | CDC Yellow Book™www.cdc.gov · www.cdc.gov
  13. Meningococcal Disease | Infection Control - CDCwww.cdc.gov · www.cdc.gov
  14. 16S Ribosomal RNA Gene PCR and Sequencing for Pediatric Infection Diagnosis, United States, 2020–2023 - Volume 31, Supplement—May 2025 - Emerging Infectious Diseases journal - CDCwwwnc.cdc.gov · wwwnc.cdc.gov
  15. Diagnostic test accuracy of jolt accentuation for headache in acute ...www.cochranelibrary.com · www.cochranelibrary.com
  16. [PDF] NG240 Meningitis (bacterial) and meningococcal disease - NICEwww.nice.org.uk · www.nice.org.uk
  17. [PDF] Meningitis (bacterial) and meningococcal disease - NICEwww.nice.org.uk · www.nice.org.uk
  18. [PDF] Meningitis (bacterial) and meningococcal disease: recognition ...www.nice.org.uk · www.nice.org.uk
  19. IDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitiswww.idsociety.org · www.idsociety.org
  20. Skin and Soft Tissue Infections - IDSAwww.idsociety.org · www.idsociety.org
  21. Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis - PMCwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  22. [PDF] Acute community-acquired bacterial meningitis in adultswww.ccjm.org · www.ccjm.org
  23. [PDF] Scientific advice under Article 107(6) of Regulation (EU)www.ema.europa.eu · www.ema.europa.eu
  24. Adult bacterial meningitis: aetiology, penicillin susceptibility, risk ...www.sciencedirect.com · www.sciencedirect.com